Viviora Lifesciences Private Limited
Indian Pharmaceutical Exporter ยท Advanced Oncology Specialist ยท $77.1K Total Trade ยท DGFT Verified
Viviora Lifesciences Private Limited is an Indian pharmaceutical exporter with a total trade value of $77.1K across 2 products in 2 therapeutic categories. Based on 7 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ifosfamide ($53.9K), Vinblastine ($23.2K), .
Viviora Lifesciences Private Limited โ Export Portfolio & Destination Treemap

Who is Viviora Lifesciences Private Limited? โ Company Overview & Market Position
Viviora Lifesciences Private Limited, established on December 6, 2017, is a private pharmaceutical company headquartered in Pune, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U74999PN2017PTC173716. Its authorized and paid-up capital are both โน100,000. The registered office is located at Plot No 12, Sr No 253/2/2, Tirumala Industrial Estate, Road Rajiv Gandhi IT Park Phase 2, Hinjawadi, Pune, Maharashtra, 411057.
Viviora Lifesciences specializes in the formulation and development of pharmaceutical products, focusing on finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. The company's portfolio includes a diverse range of oral dosage forms, including tablets, capsules, syrups, sachets, injectables, specialized products for cancer treatment, critical care items, and topical preparations.
As of the latest available data, Viviora Lifesciences has reported a total export value of $77,000 USD across seven shipments, exporting two products across two therapeutic categories. The top five products include Ifosfamide ($54,000, Rank #8, 2.2% market share) and Vinblastine ($23,000, Rank #8, 3.1% market share). The primary therapeutic categories are Advanced Oncology (69.8%) and Oncology (30.2%). The company's portfolio is highly concentrated, with the top five products accounting for 100% of its exports.